treated aggressively, even though most prostate cancers are slow-growing and will never pose a risk to a man's life, according to a study conducted by researchers from The Cancer Institute of New Jersey and UMDNJ-Robert Wood Johnson Medical School, and published in the Archives of Internal ...
Significant Weight Gained By 70 Percent Of Prostate Cancer Patients On ADT In 1st YearAnnette Whibley
Patients with prostate cancer may have more of the complexed form of prostate-specific antigen (PSA) in the serum, whereas patients with benign prostatic hyperplasia have less of this complexed form and thus a higher proportion of the free form. However, the molecular basis for the lower ...
Impact of the percentage of positive pros- tate cores on prostate cancer-specific mortality for patients with low or favorable intermediate-risk disease. J Clin Oncol 2004;22:3726--32.D'Amico AV, Renshaw AA, Cote K, Hurwitz M, Beard C, Loffredo M, et al. Impact of the percentage of ...
Prospective validation of %p2PSA and the Prostate Health Index, in prostate cancer detection in initial prostate biopsies of Asian men, with total PSA 4-10... Despite its widespread use for prostate cancer screening, low specificity makes PSA a suboptimal biomarker, especially in the diagnostic "...
Prostate cancer Diagnosis Prostate-specific antigen Percent free PSA Chinese population ROC curve 1. Introduction Prostate cancer (PCa) is the second-most frequently diagnosed malignancy in men globally [1]. Although the incidence of PCa in China is much lower than in Western countries [2], PCa ...
Value of free-to-total prostate-specific antigen ratio for detection and staging of prostate cancer. Background. We aimed to evaluate the clinical usefulness of measurement of the free-to-total (F/T) ratio of prostate-specific antigen (PSA) for the differ... Y Furuya,K Akakura,H Ito - ...
Radical treatment such as surgery and radiation for localized prostate cancer may cause significant side effects. Active surveillance is increasingly accepted as an option for treating patients with clinically insignificant disease to maintain their qual
The performance characteristics of percent free (f) prostate specific antigen (PSA) for differentiating between benign prostatic hyperplasia and prostate cancer were originally established using primarily sextant biopsy. We determined whether the addition of 6 laterally directed cores to the traditional sexta...
PSA screening cuts deaths from prostate cancer by some 30 percent. This research was based on data of 20,000 men monitored for more than two decades. The men's initially measured PSA levels proved highly significant as a predictor of future cancer risk.